510(k) K150358

Device
Gold Standard Diagnostics AIX1000 Rapid Plasma Reagin (RPR) Automated Test System
Applicant
GOLD STANDARD DIAGNOSTICS
510(k) number
K150358
Product code
GMQ  
Decision
Substantially Equivalent (SESE)
Decision date
2015-11-12
Date received
2015-02-12
Regulation
866.3820
Classification name
Antigens, Nontreponemal, All
Medical specialty
Microbiology
Review panel
Microbiology
Device class
2
Clearance type
Traditional
Statement or summary
Summary
Third party reviewed
No

Applicant Contact#

Contact
NAPOLEON MONCE
Address
2851 Spafford Davis CA US 95618 95618

FDA Registration Numbers#

Source Documents#

510(k) summary PDF

Other 510(k) Records For Product Code GMQ  #

510(k), Device, Applicant table
510(k)DeviceApplicantDecision date
K250249Gold Standard Diagnostics (GSD) AIX1000 Rapid Plasma Reagin (RPR) Automated Test SystemGold Standard Diagnostics, LLC2025-10-10
K201438ASI Automated RPR (rapid plasma reagin) Test for Syphilis, for use on the ASI Evolution Automated Syphilis AnalyzerArlington Scientific, Inc. (Asi)2020-10-21
K182391ASI Automated ASI RPR Test for Syphilis on the ASI EvolutionArlington Scientific, Inc. (Asi)2018-11-30
K173376ASI EvolutionArlington Scientific, Inc. (Asi)2018-06-14
K000687THE DAYA SYPHILIS TEST/THE TRUST ANTIGEN TESTBeacon Biologicals, Inc.2000-06-12
K993633SYNTHETIC VDRL ANTIGENCenters for Disease Control and Prevention2000-02-23
K992124AVANTI POLAR LIPIDS VDRL ANTIGEN SLIDE TEST KIT WITH 10 X 0.5 ML AMPULES, AVANTI POLAR LIPIDS BULK BDRL ANTIGEN, AVANTIAvanti Polar Lipids, Inc.1999-09-20
K954994TRUSTGuardian Scientific, Corp.1996-10-18
K955136RPR CARD TEST KITRemel, L.P.1996-07-29
K952802VISUWELL REAGIN IIBiomira Diagnostics, Inc.1996-05-23
K910541BIOKIT RPRBiokit USA, Inc.1991-10-18
K904496CROMATEST SYPHILIS DIAGNOSTICBiotrax, Inc.1991-07-24
K900338VISUWELL(R) REAGIN TEST (MODIFICATION)Adi Diagnostics, Inc.1990-04-10
K880144STANBIO SYPHILIS RPR TEST, NO. 1170Stanbio Laboratory1988-05-23
K880165TRUST RPR TEST FOR SYPHILIS IN SERUM OR PLASMAAmpcor, Inc.1988-03-30

Legacy Summary#

summary

FDA Review#

Decision Summary